1. Survey of Clinical Protocols for the Use of 177 Lu-PSMA-617 in the United States.
- Author
-
Kuo PH, Covington MF, Lee DJ, Wong TZ, and Pandit-Taskar N
- Subjects
- Humans, United States, Surveys and Questionnaires, Prostatic Neoplasms radiotherapy, Prostate-Specific Antigen, Dipeptides therapeutic use, Heterocyclic Compounds, 1-Ring, Lutetium, Clinical Protocols
- Abstract
Although guidelines for the use of
177 Lu-PSMA-617 published by various organizations are important, they do not include all the essential, practical points necessary for a complete institutional protocol. Therefore, a brief survey was performed to assess key components of the177 Lu-PSMA-617 protocol before, during, and after delivery of therapy. This survey demonstrated the wide variability in many aspects of institutional protocols regarding determination of eligibility for and administration of177 Lu-PSMA-617 therapy. The real-world protocol details provided here from a variety of institutions may help new and established theranostic programs., (© 2024 by the Society of Nuclear Medicine and Molecular Imaging.)- Published
- 2024
- Full Text
- View/download PDF